Resources
AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.
To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database
Results
showing 1-10 of 120
Years Ahead in HIV Prevention Research: Time to Market
This timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.
Prevention Option:
The Years Ahead in Biomedical HIV Prevention Research
This graphic shows the updated status of large-scale prevention trials through the end of 2024.
The HIV Prevention Pipeline
This graphic shows currently available options for HIV prevention, newly approved and recommended treatment, and those in development.
Prevention Option:
PrEP That Booty: The latest on rectal microbicide research for the back door
Most of what we hear about regarding the HIV prevention pipeline is about long-acting, longer-acting, and even longer-acting products that deliver drug throughout the body and require a trained clinician to deliver.
Prevention Option:
Current trends for investment in HIV prevention R&D by technology
Overall numbers by year. For more detailed information, visit www.hivresourcetracking.org.
Prevention Option:
New Products Are Needed But a New Paradigm is Essential
This episode of PxPulse explores the shifting landscape in HIV prevention and how this moment gives the world a chance to finally reimagine how to DELIVER prevention.
Prevention Option:
The Future of ARV-Based Prevention and More
The pipeline of non-vaccine HIV prevention products includes oral pills, vaginal rings, vaginal and rectal gels, vaginal films, long-acting injectable antiretrovirals and more. Also pictured are the range of MPTs in development that aim to reduce...
Prevention Option:
Access to the Dapivirine Vaginal Ring: A timeline on progress
This infographic shows the timeline of progress for end user access to Dapivirine Vaginal Ring.
Prevention Option:
Statement on the Dapivirine Ring for Women: Call for Accelerated Global Access
A coalition of advocates applauds the WHO for its ongoing support and its 2021 recommendation of the dapivirine vaginal ring as an additional prevention option for women.
Prevention Option:
hivresourcetracking.org
The most up-to-date and comprehensive field-wide estimates for HIV prevention and R&D globally.
Prevention Option:
showing 1-10 of 120